Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)

NCT01179776 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarct

Interventions

DRUG: Ilomedin
DRUG: Placebo
DRUG: Ilomedin
DRUG: Ilomedin and standard low dose treatment

Sponsor

Thrombologic ApS

Collaborators

[object Object]
[object Object]